MIR3925

Across TCGA pan-cancer cohorts, MIR3925 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR3925 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR3925 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3925 expression acts as an unfavorable survival marker.

COAD, UCEC, and ESCA are the cancer types where MIR3925 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.422	0.787	.001	72	view →
UCEC	DFS	Tertile	All	0.101	0.649	<.001	72	view →
ESCA	OS	Tertile	II,III,IV	0.265	0.543	.002	48	view →
READ	OS	Tertile	All	0.528	0.932	<.001	39	view →
BRCA	DFS	Tertile	All	0.710	0.905	.001	36	view →
LUAD	OS	Tertile	III,IV	0.314	0.684	.028	21	view →
STAD	DFS	Tertile	IV	0.090	0.492	<.001	18	view →
GBM	OS	Tertile	All	0.060	0.420	<.001	18	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
LAML	DFS	Quartile	All	0.208	0.453	.015	14	view →
KIRP	OS	Tertile	All	0.157	0.704	.029	9	view →
LIHC	DFS	Tertile	All	0.146	0.530	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR3925–COAD (DFS)

Open the COAD breakdown →